BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 7901825)

  • 1. Amplification of the c-erbB-2 gene in gastric carcinoma: correlation with survival.
    Tsugawa K; Fushida S; Yonemura Y
    Oncology; 1993; 50(6):418-25. PubMed ID: 7901825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic alterations in c-erbB-2 protooncogene as prognostic markers in human primary breast tumors.
    Nagai MA; Marques LA; Torloni H; Brentani MM
    Oncology; 1993; 50(6):412-7. PubMed ID: 7901824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification of the c-met, c-erbB-2 and epidermal growth factor receptor gene in human gastric cancers: correlation to clinical features.
    Tsugawa K; Yonemura Y; Hirono Y; Fushida S; Kaji M; Miwa K; Miyazaki I; Yamamoto H
    Oncology; 1998; 55(5):475-81. PubMed ID: 9732228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. erbB-2 expression in well-differentiated adenocarcinoma of the stomach predicts shorter survival after curative resection.
    Motojima K; Furui J; Kohara N; Izawa K; Kanematsu T; Shiku H
    Surgery; 1994 Mar; 115(3):349-54. PubMed ID: 7907434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-amplification of c-myc and c-erbB-2 oncogenes in a poorly differentiated human gastric cancer.
    Tsuchiya T; Ueyama Y; Tamaoki N; Yamaguchi S; Shibuya M
    Jpn J Cancer Res; 1989 Oct; 80(10):920-3. PubMed ID: 2575609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of c-erbB-2 in human esophageal carcinoma cells: overexpression correlated with gene amplification or with GATA-3 transcription factor expression.
    Shiga K; Shiga C; Sasano H; Miyazaki S; Yamamoto T; Yamamoto M; Hayashi N; Nishihira T; Mori S
    Anticancer Res; 1993; 13(5A):1293-301. PubMed ID: 7902061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
    Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
    Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas.
    Park JB; Rhim JS; Park SC; Kimm SW; Kraus MH
    Cancer Res; 1989 Dec; 49(23):6605-9. PubMed ID: 2573419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix.
    Kihana T; Tsuda H; Teshima S; Nomoto K; Tsugane S; Sonoda T; Matsuura S; Hirohashi S
    Cancer; 1994 Jan; 73(1):148-53. PubMed ID: 7506116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study on the expression of c-erbB-2 oncoprotein in breast cancer.
    Horiguchi J; Iino Y; Takei H; Yokoe T; Ishida T; Morishita Y
    Oncology; 1994; 51(1):47-51. PubMed ID: 7903441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of C-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer.
    Mizutani T; Onda M; Tokunaga A; Yamanaka N; Sugisaki Y
    Cancer; 1993 Oct; 72(7):2083-8. PubMed ID: 8397058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus.
    Nakamura T; Nekarda H; Hoelscher AH; Bollschweiler E; Harbeck N; Becker K; Siewert JR; Harbec N [corrected to Harbeck N]
    Cancer; 1994 Apr; 73(7):1785-94. PubMed ID: 7907940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-erbB-2 expression in primary gastric carcinomas and their metastases.
    David L; Seruca R; Nesland JM; Soares P; Sansonetty F; Holm R; Børresen AL; Sobrinho-Simões M
    Mod Pathol; 1992 Jul; 5(4):384-90. PubMed ID: 1353880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of fine-needle aspiration to the demonstration of ERBB2 and MYC expression by in situ hybridization in breast carcinoma.
    Soini Y; Mannermaa A; Winqvist R; Kamel D; Poikonen K; Kiviniemi H; Pääkkö P
    J Histochem Cytochem; 1994 Jun; 42(6):795-803. PubMed ID: 7910618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular biology and immunohistochemical studies of Her2/neu oncogene in stomach cancer].
    Jähne J; Urmacher C; Albino A; Meyer HJ; Pichlmayr R
    Chirurg; 1994 Apr; 65(4):307-11. PubMed ID: 7912666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease.
    Dawkins HJ; Robbins PD; Smith KL; Sarna M; Harvey JM; Sterrett GF; Papadimitriou JM
    Pathol Res Pract; 1993 Dec; 189(10):1233-52. PubMed ID: 7910395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of c-erbB-2 amplification and DNA aneuploidy. Analysis in 78 patients with node-negative breast cancer.
    Babiak J; Hugh J; Poppema S
    Cancer; 1992 Aug; 70(4):770-6. PubMed ID: 1353701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients.
    Uchino S; Tsuda H; Maruyama K; Kinoshita T; Sasako M; Saito T; Kobayashi M; Hirohashi S
    Cancer; 1993 Dec; 72(11):3179-84. PubMed ID: 7902202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
    Gaffey MJ; Frierson HF; Williams ME
    Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification of epidermal growth factor receptor gene and its relationship to survival in human gastric cancer.
    Hirono Y; Tsugawa K; Fushida S; Ninomiya I; Yonemura Y; Miyazaki I; Endou Y; Tanaka M; Sasaki T
    Oncology; 1995; 52(3):182-8. PubMed ID: 7715901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.